全文获取类型
收费全文 | 11565篇 |
免费 | 600篇 |
国内免费 | 54篇 |
专业分类
耳鼻咽喉 | 78篇 |
儿科学 | 170篇 |
妇产科学 | 178篇 |
基础医学 | 1576篇 |
口腔科学 | 517篇 |
临床医学 | 849篇 |
内科学 | 2702篇 |
皮肤病学 | 199篇 |
神经病学 | 841篇 |
特种医学 | 663篇 |
外科学 | 1855篇 |
综合类 | 61篇 |
预防医学 | 402篇 |
眼科学 | 236篇 |
药学 | 692篇 |
中国医学 | 8篇 |
肿瘤学 | 1192篇 |
出版年
2023年 | 53篇 |
2022年 | 113篇 |
2021年 | 208篇 |
2020年 | 104篇 |
2019年 | 122篇 |
2018年 | 213篇 |
2017年 | 156篇 |
2016年 | 200篇 |
2015年 | 183篇 |
2014年 | 224篇 |
2013年 | 274篇 |
2012年 | 507篇 |
2011年 | 551篇 |
2010年 | 270篇 |
2009年 | 258篇 |
2008年 | 477篇 |
2007年 | 457篇 |
2006年 | 507篇 |
2005年 | 492篇 |
2004年 | 468篇 |
2003年 | 481篇 |
2002年 | 513篇 |
2001年 | 416篇 |
2000年 | 457篇 |
1999年 | 452篇 |
1998年 | 156篇 |
1997年 | 124篇 |
1996年 | 111篇 |
1995年 | 83篇 |
1994年 | 106篇 |
1993年 | 102篇 |
1992年 | 321篇 |
1991年 | 310篇 |
1990年 | 274篇 |
1989年 | 274篇 |
1988年 | 286篇 |
1987年 | 247篇 |
1986年 | 228篇 |
1985年 | 209篇 |
1984年 | 159篇 |
1983年 | 99篇 |
1982年 | 52篇 |
1979年 | 122篇 |
1978年 | 66篇 |
1977年 | 60篇 |
1976年 | 58篇 |
1975年 | 61篇 |
1974年 | 57篇 |
1973年 | 54篇 |
1971年 | 52篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
991.
Tsujinaka S Kawamura YJ Konishi F Aihara H Maeda T Mizokami K 《International journal of colorectal disease》2008,23(1):67-76
Background and aims The purpose of this study was to assess the long-term efficacy of preoperative radiotherapy for locally advanced low rectal
cancer.
Materials and methods Between April 1990 and June 2005, all patients who underwent surgery for low rectal cancer with a pretreatment diagnosis of
T3 or resectable T4 without distant metastasis were enrolled. The total dose of radiation was 45 Gy. Patients with a partial
or complete response were defined as radiotherapy responders (RT-R) and the others as radiotherapy non-responders (RT-NR).
Patients who did not receive radiotherapy were termed the non-radiotherapy group (NRT). The endpoint of this study was overall
survival and local and/or distant metastasis.
Results There were 24 patients in RT-R, 26 in RT-NR, and 40 in NRT. Gastrointestinal complications were commonly observed in all groups.
RT-R had a significantly higher incidence of genitourinary complications. Five-year overall survival rate was 79.6% in RT-R,
58.9% in RT-NR, and 58.8% in NRT. The difference was significant in favor of RT-R over the others (P = 0.015, 0.024, respectively). Five-year local recurrence-free survival rate was 100% in RT-R, 81.5% in RT-NR, and 74.9% in
NRT. RT-R had significantly improved local control compared with the others (P = 0.034, 0.021, respectively). Five-year distant metastasis-free survival was not statistically different among all groups.
Conclusions Survival benefit of preoperative radiotherapy was limited to responders. Considering the increased risk of adverse effects,
identification of predictors of radiosensitivity is required in order to provide the most suitable treatment for individual
patients. 相似文献
992.
Niwa Y Nakamura M Ohmiya N Maeda O Ando T Itoh A Hirooka Y Goto H 《Journal of gastroenterology》2008,43(4):270-276
Background Although obscure gastrointestinal bleeding cannot be detected by colonoscopy or upper endoscopy, wireless video capsule endoscopy
(VCE) is capable of imaging it. Few data are available on medical therapy for patients with nonsteroidal anti-inflammatory
drug (NSAID)-induced small-intestinal mucosal injuries. The aim of this study was to compare prevention by rebamipide and
placebo of NSAID-induced smallintestinal injury in healthy subjects.
Methods Ten healthy subjects who provided written informed consent were enrolled. Rebamipide or placebo plus diclofenac was administered
with omeprazole for 7 days, and for an additional 7-day period with treatments reversed in the same subjects, with a 4-week
washout period between treatments. VCE of the small intestine was performed four times, before and after each of the two study
periods.
Results The number of subjects with small-intestinal mucosal injuries was higher in the placebo group (8/10) than in the rebamipide
group (2/10) (P = 0.023). Two cases of ulcer and one of bleeding were observed in the placebo group, while no ulcer or bleeding was observed
in the rebamipide group.
Conclusions Rebamipide had significantly higher efficacy than placebo in preventing NSAID-induced small-intestinal mucosal injury. 相似文献
993.
Targeting of heat shock protein 32 (Hsp32)/heme oxygenase-1 (HO-1) in leukemic cells in chronic myeloid leukemia: a novel approach to overcome resistance against imatinib 下载免费PDF全文
Mayerhofer M Gleixner KV Mayerhofer J Hoermann G Jaeger E Aichberger KJ Ott RG Greish K Nakamura H Derdak S Samorapoompichit P Pickl WF Sexl V Esterbauer H Schwarzinger I Sillaber C Maeda H Valent P 《Blood》2008,111(4):2200-2210
Resistance toward imatinib and other BCR/ABL tyrosine kinase inhibitors remains an increasing clinical problem in the treatment of advanced stages of chronic myeloid leukemia (CML). We recently have identified the heat shock protein 32 (Hsp32)/heme oxygenase-1 (HO-1) as a BCR/ABL-dependent survival molecule in CML cells. We here show that silencing Hsp32/HO-1 in CML cells by an siRNA approach results in induction of apoptosis. Moreover, targeting Hsp32/HO-1 by either pegylated zinc protoporphyrine (PEG-ZnPP) or styrene maleic acid-micelle-encapsulated ZnPP (SMA-ZnPP) resulted in growth inhibition of BCR/ABL-transformed cells. The effects of PEG-ZnPP and SMA-ZnPP were demonstrable in Ba/F3 cells carrying various imatinib-resistant mutants of BCR/ABL, including the T315I mutant, which exhibits resistance against all clinically available BCR/ABL tyrosine kinase inhibitors. Growth-inhibitory effects of PEG-ZnPP and SMA-ZnPP also were observed in the CML-derived human cell lines K562 and KU812 as well as in primary leukemic cells obtained from patients with freshly diagnosed CML or imatinib-resistant CML. Finally, Hsp32/HO-1-targeting compounds were found to synergize with either imatinib or nilotinib in producing growth inhibition in imatinib-resistant K562 cells and in Ba/F3 cells harboring the T315I mutant of BCR/ABL. In summary, these data show that HO-1 is a promising novel target in imatinib-resistant CML. 相似文献
994.
Okabayashi T Nishimori I Sugimoto T Maeda H Dabanaka K Onishi S Kobayashi M Hanazaki K 《Journal of gastroenterology and hepatology》2008,23(12):1869-1873
Background and Aims: Most patients with hepatocellular carcinoma (HCC) have underlying liver cirrhosis that is frequently associated with a state of protein energy malnutrition. The aim of this study was to evaluate the clinical benefit of perioperative supplementation of a branched‐chain amino acid–enriched nutrient‐mixture for patients undergoing liver resection for HCC. Methods: A total of 112 patients with HCC who underwent hepatic resection were enrolled in this study. These patients were divided into two groups: 40 patients received perioperative supplementation of branched‐chain amino acid–enriched nutrient‐mixture (AEN group) and 72 patients did not (control group). Laboratory data, postoperative complications, duration of hospitalization, and survival were assessed for each group and compared. Results: The overall incidence of postoperative complications was lower in the AEN group (17.5%) than in the control group (44.4%) (P = 0.01). Among the postoperative complications, surgical site infection and bile leakage was observed in 5% of patients in the AEN group and in 15.3% and 12.5% of patients in the control group, respectively. Ascites appeared after the surgery in 7.5% of patients in the AEN group and in 16.7% of patients in the control group. The duration of hospitalization was significantly shorter in the AEN group was than in the control group (P < 0.05). Conclusions: This study strongly suggests that perioperative supplementation of a branched‐chain amino acid–enriched nutrient‐mixture is clinically beneficial in reducing the morbidity associated with postoperative complications and in shortening the duration of hospitalization of patients with chronic liver disease who undergo liver resection for HCC. 相似文献
995.
Miyazato H Nakatsuka S Miyanaga I Hanamoto H Tatsumi Y Matsuda M Maeda Y Kanamaru A Aozasa K;Osaka Lymphoma Study Group 《International journal of hematology》2002,76(4):333-337
Follicular lymphoma (FL) is defined as a neoplastic proliferation of follicle center cells with varying follicular areas. To learn the time trend of FL in the Osaka area, an adult T-cell leukemia/lymphoma (ATL) nonendemic area of Japan, we examined the frequency of FL among all non-Hodgkin's lymphomas (NHLs) during the period 1964 to 1987 (n = 1,000) and 1999 to 2001 (n = 659).The frequency of FL with varying follicular areas increased from 1964-1987 to 1999-2001.There was a significant difference in frequency of total cases of FL (14.2% versus 18.8%) (P < .05) and FL with no to 25% follicular area (2.3% versus 5.0%) (P < .01). According to the Berard criteria, cytologic grade of FL was defined by counting the number of centroblasts (CB) in 10 neoplastic follicles as follow: < or = 5 CB per high power field (HPF), grade 1; 6-15 CB, grade 2; >15 CB, grade 3. Immunohistochemical staining with monoclonal antibodies for bcl-2 and CD10 was performed. There was an inverse correlation between follicular area and cytological grade (P < .0001) and bcl-2 expression and cytological grade (P < .01). That is, the larger the follicular area in cases with a lower cytological grade, the stronger was bcl-2 expression in a lower cytological grade. There was a significant correlation between follicular area and stage of disease (P < .05). That is, the follicular area was larger in cases in an advanced stage. This study showed the increase in frequency of FL in Osaka, Japan. Change of lifestyle in Japan may be one of the causative factors for the increase. 相似文献
996.
Recurrence of Helicobacter pylori infection and the long-term outcome of peptic ulcer after successful eradication in Japan. 总被引:8,自引:0,他引:8
Mitsuru Seo Mitsuo Okada Takuro Shirotani Hirokatsu Nishimura Kazuhiro Maeda Kunihiko Aoyagi Shotaro Sakisaka 《Journal of clinical gastroenterology》2002,34(2):129-134
Recurrence of peptic ulcer after successful eradication of Helicobacter pylori is closely associated with reinfection. The aim of this study was to examine the recurrence of peptic ulcer and reinfection with H. pylori after successful eradication. To eradicate H. pylori infection, patients with active peptic ulcer disease were assigned to two treatment groups depending on the year of their enrollment (AM group and OAMR group). Patients in the AM group received 400 mg of cimetidine twice per day, 300 mg of amoxicillin three times per day, and 250 mg of metronidazole three times per day for 2 weeks. Patients in the OAMR group received 20 mg of omeprazole once per day, 500 mg of amoxicillin granules three times per day, 250 mg of metronidazole three times per day, and 150 mg of roxithromycin twice per day for 1 week. After endoscopy verified ulcer scarring and successful eradication of H. pylori infection, study patients were followed up monthly and did not undergo acid-suppressive therapy. Endoscopy was performed at 6-month intervals for the 1st year. After the 1st year, follow-up endoscopies were performed annually. In total, 107 patients with peptic ulcer (duodenal ulcer [DU], 65; gastric ulcer [GU], 42) were followed up for a mean period of approximately 2 years. Recurrence of infection occurred in 10 (9.3%) of 107 patients (AM group, 9; OAMR group, 1) after 210 patient-years of follow-up; the recurrence rate was 4.8% per patient-year. Recurrence of H. pylori infection was significantly higher in the AM group (23.1%) than in the OAMR group (1.5%). H. pylori infection recurred in two patients 6 months after eradication therapy, in seven 1 year after, and in one 2 years after. Thereafter, no further cases of H. pylori recurrence were observed. During follow-up periods, seven cases of ulcer recurrence were observed (DU, 4; GU, 3). The rate of peptic ulcer recurrence within 2 years after eradication therapy was significantly higher than that after more than 2 years. Four cases of ulcer recurrence (DU, 3; GU, 1) also had recurrence of H. pylori infection. One recurrent case of DU without reinfection was associated with nonsteroidal anti-inflammatory drugs. The remaining two cases of GU recurred without H. pylori reinfection. In conclusion, peptic ulcer recurrence rarely occurred (3 [2.9%] of 103) in patients cured of H. pylori infection. Reinfection after apparent successful eradication was rarely noted when a powerful therapeutic regimen in eradication was used. Therefore, to eradicate H. pylori, a highly effective therapeutic regimen should always be used. 相似文献
997.
Tanizaki S Maeda S Hayashi H Matano H Ishida H Yoshikawa J Yamamoto T 《The American journal of emergency medicine》2012,30(2):342-346
Purposes
In this retrospective study, we reviewed our protocol consisting of early embolization without acute external fixation in patients with pelvic fracture.Patients and Methods
Eighty-eight patients with pelvic fracture were identified by reviewing the records of the Fukui Prefectural Hospital from April 2005 through September 2009. We managed the patients with a treatment protocol consisting of hemodynamic resuscitation and early pelvic embolization. Patients with hemodynamic instability without nonpelvic hemorrhage or extravasation of contrast in the pelvis by computed tomography (CT) were indicated to angiography and embolization. External fixation of the pelvic ring was not used in our protocol.Results
Of the 88 patients with pelvic fractures, 43 underwent angiography. Twenty-eight patients (65%) were hemodynamically unstable. Twenty-five patients (58%) had major ligamentous disruption. Computed tomography detected extravasation in 21 patients (48%). Of the 43 patients who underwent angiography, 29 (67%) were positive. The average time from hospital arrival to angiography was 76.3 ± 34.5 minutes. The packed red blood cell requirement in the initial 24 hours was 8.4 ± 8.2 U, required in the embolization group. There was no complication-related embolization. Repeat angiography was not required in all patients. The mortality rate of patients requiring angiography was 11%.Conclusions
Early pelvic embolization without external fixation may be useful for the initial treatment for patients with hemodynamic instability without nonpelvic hemorrhage or with extravasation of contrast in the pelvis by CT. 相似文献998.
Mashimo Y Maeda T Teramoto T 《Nihon rinsho. Japanese journal of clinical medicine》2012,70(5):852-856
Low-density lipoprotein (LDL) cholesterol is the most established risk factor for atherosclerotic disease such as coronary artery disease and cerebrovascular disease. High-density lipoprotein (HDL) cholesterol and nonHDL-C as well as small dense LDL, Remnant like particles cholesterol (RLP-C) and oxidized LDL are the secondary risk factors for atherosclerosis. It is important to integrate and control these risk factors for the prevention of atherosclerosis as a real endpoint of diagnosis and treatment of dyslipidemia. 相似文献
999.
Exacerbation of heart failure in adiponectin-deficient mice due to impaired regulation of AMPK and glucose metabolism 总被引:24,自引:0,他引:24
Liao Y Takashima S Maeda N Ouchi N Komamura K Shimomura I Hori M Matsuzawa Y Funahashi T Kitakaze M 《Cardiovascular research》2005,67(4):705-713
OBJECTIVE: Insulin resistance (IR) was reported to be associated with chronic heart failure (CHF). Adiponectin, an insulin-sensitizing hormone with anti-inflammatory activity, improves energy metabolism via AMP-activated protein kinase (AMPK). AMPK deficiency is associated with depressed cardiac function under stress conditions. However, it is not clear whether adiponectin plays an important role in CHF. We hypothesize that deficiency of adiponectin might result in deterioration of heart failure. METHODS: Using adiponectin null mice and their littermates, we examined the effects of adiponectin on LV pressure overload-induced cardiac hypertrophy and failure, and investigated the mechanisms involved. RESULTS: Three weeks after transverse aortic constriction (TAC), cardiac hypertrophy (evaluated from the heart-to-body weight ratio: 7.62+/-0.27 in wild-type (WT) mice, 9.97+/-1.13 in knockout (KO) mice, P<0.05) and pulmonary congestion (lung-to-body weight ratio: 9.05+/-1.49 in WT mice, 14.95+/-2.36 in KO mice, P<0.05) were significantly greater in adiponectin KO mice than WT mice. LV dimensions were also increased in KO mice. Compared with WT TAC mice, expression of AMPKalpha protein was lower, while IR was higher in KO TAC mice. CONCLUSION: These findings indicate that adiponectin deficiency leads to progressive cardiac remodeling in pressure overloaded condition mediated via lowing AMPK signaling and impaired glucose metabolism. 相似文献
1000.
Kusano M Minashi K Maeda M Shimoyama Y Kuribayashi S Higuchi T Sugimoto S Kawamura O Mori M 《Scandinavian journal of gastroenterology》2005,40(10):1176-1181
OBJECTIVE: The effects of postprandial water intake on the gastrointestinal tract have not been systematically investigated in humans. MATERIAL AND METHODS: In 8 healthy volunteers, the gastric antral pressure was measured with a strain gauge transducer, while the esophageal and lower esophageal sphincter pressures were measured with an infused catheter with a Dent sleeve. The esophageal pH at 5 cm above the lower sphincter was measured with a microglass electrode. A standard test meal (560 kcal) was eaten and 500 ml water was ingested 1 h later. The plasma cholecystokinin level was assessed at 4-min intervals. As a control, the same study was done on another day with sham water intake. RESULTS: At 4 min after water intake, there was a significant decrease in gastric antral motility and a significant increase in the plasma cholecystokinin level. Water intake also significantly increased the occurrence of gastroesophageal reflux. CONCLUSIONS: The rapid increase in cholecystokinin after water intake may be initiated by a feedback mechanism related to inflow of fatty chyme into the duodenum that inhibits gastric antral activity. 相似文献